Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Help paying for ALK-Positive Lung Cancer treatment

We found 7 drugmaker programs for ALK-Positive Lung Cancer medicines and 4 charity funds (0 open at our last check).

What coverage do you have?
Or jump straight to charity funds or drugmaker programs.

What to try first, depending on your coverage

Pick the one that sounds like you. We'll lay out the funds and programs for ALK-Positive Lung Cancer that fit, in the order to try them, and what won't work, so you don't waste a phone call.

Charity funds for ALK-Positive Lung Cancer

Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.

Email me when an ALK-Positive Lung Cancer fund opens

4 funds on this page aren't taking new applicants right now. We watch every foundation listed here and email you as soon as we see one open, so you can apply before the money runs out. You'll also get new ALK-Positive Lung Cancer trial alerts. Unsubscribe from either with one click.

You'll get, for ALK-Positive Lung Cancer:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site
Open now0
Taking new applicants when we checked
None at our last check.
Waitlist or ask0
Join the list or ask the fund
None at our last check.
Closed for now4
Sign up to hear when it reopens
CancerCare Co-Payment Assistance Foundation

Non-Small Cell Lung Cancer fund

Covers: Copays, coinsurance and deductibles for people with federal insurance such as Medicare, Medicaid or TRICARE. Up to $4,000 a year.

Requires Medicare, Medicaid or TRICARE
“Unfortunately, this fund is currently closed.”
Foundation's pageChecked November 18, 2026
Good Days

Non-Small Cell Lung Cancer fund

Covers: Copays for people with government insurance and income at or below 500% of the federal poverty level.

Requires Medicare, Medicaid or TRICARE
“Program Status: closed.”
Foundation's pageChecked November 20, 2026
HealthWell Foundation

Non-Small Cell Lung Cancer (Medicare Access) fund

Covers: Prescription drug copays for people with Medicare. Up to $6,000 a year.

Medicare patients only
“Temporarily closed to new patients due to lack of sufficient funding”
Foundation's pageChecked November 18, 2026
TotalAssist

Non-small cell lung cancer (NSCLC) fund

Covers: Out-of-pocket medicine costs for people with government insurance and income at or below 500% of the federal poverty level. Up to $6,000 a year.

Requires Medicare, Medicaid or TRICARE
Foundation's pageChecked November 18, 2026

Help from the companies that make ALK-Positive Lung Cancer medicines

Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.

AlecensaAlectinib

Support program: Genentech Access Solutions
Copay helpFree medicine programInsurance and case manager help
What each one covers and who qualifies
  • Copay help

    Genentech Oncology Co-pay Assistance Program: eligible commercially insured patients prescribed Alecensa for an FDA-approved use can receive up to $25,000 in assistance per product per calendar year. Not valid when the prescription is reimbursed under any federal or state government program. Call (855) MY-COPAY (855-692-6729), 9 a.m. to 8 p.m. ET, Monday through Friday.

    For: Private insurance · source
  • Free medicine program

    Genentech Patient Foundation: people without health insurance coverage, or with financial concerns, who meet eligibility criteria may get Alecensa at no cost. Insured patients with coverage for the medicine should first pursue other forms of financial help if available, and both groups must meet income requirements. Call (888) 941-3331.

    For: No insurance, underinsured · source
  • Insurance and case manager help

    Alecensa Access Solutions can check insurance coverage and prior authorization needs, help with appeals resources, and refer eligible patients with commercial or public insurance to independent co-pay foundations that support lung cancer. Genentech Access Solutions can be reached at (877) GENENTECH / (877) 436-3683.

    For: Private insurance, Medicare, Medicaid · source

Read on November 18, 2026 from the Genentech Pro Alecensa financial assistance section, the Genentech Oncology Co-pay Assistance Program site (copayassistancenow.com, which only renders in a browser) and Genentech's patient support services page. The old genentech-access.com Alecensa patient links now redirect to gene.com/patients/patient-support-services. Genentech does not publish the Patient Foundation income limits on these pages. The foundations Genentech lists for lung cancer are CancerCare Co-Payment Assistance Foundation, Good Days from CDF, Musella Foundation, Patient Access Network Foundation, Patient Advocate Foundation, The Assistance Fund and HealthWell; their fund status was not checked here.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

AlunbrigBrigatinib

Support program: Takeda Oncology Here2Assist
Copay helpInsurance and case manager help
What each one covers and who qualifies
  • Copay help

    Takeda Oncology Co-pay Assistance Program: eligible commercially insured patients may pay as little as $0 per prescription. Must be 18 or older and live in the US or a US territory, with private insurance that does not cover the full cost. Not valid when any part of the prescription can be paid by Medicare, Medicare Advantage, Medigap, Medicaid, DoD, VA, TRICARE, Puerto Rico Government Insurance or a state assistance program. Valid for 12 months and renewable. No income requirement. The page gives no annual maximum.

    For: Private insurance · source
  • Insurance and case manager help

    Here2Assist case managers help with insurance coverage, finding financial assistance, choosing a specialty pharmacy and follow-up calls. For people with Medicare, Medicaid or TRICARE, Takeda points to nonprofits, social workers and Medicare Part D Extra Help. Call 1-844-817-6468, Option 2, Monday to Friday, 8 AM to 8 PM ET. Enrollment form fax 1-844-269-3038.

    For: Private insurance, Medicare, Medicaid, No insurance · source

Copay and case manager terms read on alunbrig.com/here2assist on November 18, 2026. Third-party listings describe a Takeda Oncology Patient Assistance Program (free drug) and a RapidStart free first-month supply for Alunbrig, but neither alunbrig.com nor here2assist.com showed their terms when read, and they are left out until Takeda's own page confirms them.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

EnsacoveEnsartinib

Support program: XcoveryCares
Copay help
What each one covers and who qualifies
  • Copay help

    XcoveryCares Co-Pay Assistance Program for commercially insured patients 18 or older in the US or a US territory whose private insurance does not cover the full cost. Not valid when any part of the prescription can be paid by Medicare, Medicare Advantage, Medigap, Medicaid, DoD, VA, TRICARE or another government program. Covers 1 calendar year and may be renewed. No income requirement. The page states no dollar amount or annual maximum. For questions, call 1-888-215-8384, Monday to Friday, 8 AM to 8 PM ET.

    For: Private insurance · source

Read on ensacove.com/financial-support on November 18, 2026; the page blocks plain downloads and was read through a page fetch. The page names only the co-pay program and an XcoveryCares patient enrollment form (PDF, could not be read as text) and offers sample appeal and medical necessity letters. No free-drug program, bridge supply or named specialty pharmacy appears on the page. A third-party drug price site lists 866-367-2260 for XcoveryCares, which does not appear on ensacove.com and was not used.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

LorbrenaLorlatinib

Support program: Pfizer Oncology Together
Copay helpFree medicine programInsurance and case manager help
What each one covers and who qualifies
  • Copay help

    Pfizer Oncology Together Co-Pay Savings Program: eligible commercially insured patients may pay as little as $0 per month for Lorbrena, with a maximum benefit of $10,600 per product per calendar year. Not for anyone enrolled in Medicare, Medicaid, TRICARE, VA health care, a state prescription drug assistance program or Puerto Rico's government health plan, and not for cash-paying patients. Patients must be 18 or older. The current offer expires December 31, 2026.

    For: Private insurance · source
  • Free medicine program

    Pfizer Patient Assistance Program: for eligible people with Medicare, Medicaid or other government insurance who have a financial need and cannot get help from other funding sources or Medicare Extra Help, Pfizer Oncology Together checks eligibility for free medicine. Eligible uninsured people who do not qualify for Medicaid may get Lorbrena free for up to 1 year and must reapply as needed.

    For: Medicare, Medicaid, No insurance · source
  • Insurance and case manager help

    Pfizer Oncology Together helps patients understand their insurance benefits and connects them with financial assistance resources whatever their coverage, including help searching for outside funding and Medicare Extra Help and checking Medicaid eligibility for uninsured patients. Call 1-877-744-5675, Monday to Friday, 8 AM to 8 PM ET.

    For: Private insurance, Medicare, Medicaid, No insurance · source

Terms read on November 18, 2026 from the Pfizer Oncology Together co-pay terms page and the Lorbrena support page. The Pfizer Patient Assistance Program is run with the Pfizer Patient Assistance Foundation, which Pfizer describes as a separate legal entity. Pfizer does not publish the income limits for free medicine on these pages. The co-pay offer expires December 31, 2026, and needs a recheck in January 2027.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

NelkarmiNeladalkib

Support program: Nuvalent Patient Support
Insurance and case manager help
What each one covers and who qualifies
  • Insurance and case manager help

    Nuvalent Patient Support lists Nelkarmi 50mg and 150mg tablets. Its Nelkarmi page says the program is coming soon and gives (844) 688-5333, Monday to Friday 8 AM to 8 PM ET, to enroll or learn more.

    The drugmaker's page doesn't say who qualifies, so ask the program. · source

The FDA granted accelerated approval on November 17, 2026. Nuvalent, now part of GSK, has published no copay card amount, free-drug program, eligibility rules or list price for Nelkarmi. nelkarmi.com was not live and GSK's TogetherWithGSK site does not list Nelkarmi. Check again once the Nelkarmi support page goes live. Every non-small cell lung cancer charity fund checked on November 18, 2026 was closed.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

XalkoriCrizotinib

Support program: Pfizer Oncology Together
Copay helpFree medicine programInsurance and case manager help
What each one covers and who qualifies
  • Copay help

    Pfizer Oncology Together Co-Pay Savings: eligible commercially insured patients may pay as little as $0 per month, with up to $10,600 per product in savings each year. Not for anyone enrolled in a state or federally funded program such as Medicare, Medicaid, TRICARE or VA health care.

    For: Private insurance · source
  • Free medicine program

    Pfizer Patient Assistance Program: may provide prescribed Pfizer Oncology medicines free to eligible patients who are uninsured or have government insurance and cannot afford their out-of-pocket costs. People with Medicare are first helped to look for other funding such as Extra Help; uninsured people are first helped to check Medicaid. Commercially insured patients are not eligible.

    For: No insurance, Medicare, Medicaid · source
  • Insurance and case manager help

    Pfizer Oncology Together helps people understand insurance benefits, and find financial help. Call 1-877-744-5675, Monday to Friday, 8am to 8pm Eastern.

    For: Private insurance, Medicare, Medicaid, No insurance · source

The xalkori.com financial assistance page and the Pfizer Oncology Together financial assistance page both state the $0 per month and $10,600 per product yearly co-pay terms. The Terms and Conditions block on xalkori.com still prints an older Co-Pay One card ($10 per 30-day prescription, $25,000 a year, program expires 12/31/2017); the record uses the current $0 and $10,600 terms shown on both pages. Neither page names a bridge or quick-start supply for Xalkori. No income limits are published for the free medicine program.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

ZykadiaCeritinib

Support program: Novartis Oncology Universal Co-pay Program
Copay helpFree medicine program
What each one covers and who qualifies
  • Copay help

    Novartis Oncology Universal Co-pay Program: lists Zykadia in its medication selector. Under the general terms, privately insured patients are responsible for up to the first $25, with the specific offer varying by brand, and a combined annual limit of $15,000 per calendar year. Not for anyone enrolled in Medicare, Medicaid, TRICARE, VA, DoD or other federal or state programs, and not valid for Massachusetts patients. California patients must meet additional eligibility criteria, which the site does not spell out. Call 1-877-577-7756.

    For: Private insurance · source
  • Free medicine program

    Novartis Patient Assistance Foundation (NPAF): provides Novartis medicines free of cost to eligible patients who are uninsured or have government insurance, live in the US or a US territory, are treated by a licensed US provider as outpatients and meet income guidelines. Zykadia (ceritinib) is on its list of supported medicines. Call 1-800-277-2254.

    For: No insurance, Medicare, Medicaid · source

Partial: the co-pay site gives only general terms for all Novartis oncology brands ('specific offer varies by brand') and lists Zykadia as capsules, which Drugs@FDA marks as discontinued; no Zykadia-specific co-pay terms were found. NPAF does not publish its income limits, and neither page lists hours. Novartis's September 2024 Financial Support sheet also lists a Zykadia co-pay program at 1-844-638-7222. zykadia.com redirected to the Novartis product list on November 18, 2026, and Novartis's Zykadia product page links only to the label and the NPAF enrollment page. The Novartis co-pay page states 2 different yearly limits, $30,000 and a combined $15,000; this record shows the $15,000 figure until Novartis confirms which applies to Zykadia.

Read on the drugmaker's site November 18, 2026. Programs change, so confirm before you rely on it.

Before you pick up the phone

Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.

Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.

Questions people ask about paying for ALK-Positive Lung Cancer treatment

Is there financial help for ALK-Positive Lung Cancer treatment?

Yes. Trial Friend lists 7 drugmaker programs for ALK-Positive Lung Cancer medicines and 4 charity funds, 0 of them open at our last check. We checked every one at the source on or before November 20, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.

Can I use a copay card for ALK-Positive Lung Cancer medicine if I have Medicare?

No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For ALK-Positive Lung Cancer, 0 charity funds on this page accept Medicare, and 3 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.

Which ALK-Positive Lung Cancer charity funds are open right now?

None of the 4 funds listed for ALK-Positive Lung Cancer was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.

What help is there for ALK-Positive Lung Cancer treatment without insurance?

Of the drugmaker programs for ALK-Positive Lung Cancer medicines, 4 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.

Where to go next

How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (CancerCare Co-Payment Assistance Foundation, Good Days, HealthWell Foundation, TotalAssist) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.